Treatment of rheumatoid arthritis during pregnancy: present and future
- 3 May 2016
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Clinical Immunology
- Vol. 12 (9), 937-944
- https://doi.org/10.1080/1744666x.2016.1184973
Abstract
For the management of rheumatoid arthritis patients who plan to become pregnant, both disease activity and therapeutic regimens have to be taken into consideration. In the case of stable inactive disease, pregnancy can be planned and therapy can be adjusted with drugs compatible with pregnancy. Drugs to be discontinued before pregnancy are methotrexate, leflunomide, tocilizumab, rituximab, abatacept and tofacitinib. Pregnancy compatible disease modifying drugs are antimalarial drugs and sulfasalazine. TNF-inhibitors can be continued during the first half of pregnancy, yet if indicated during the third trimester TNF-inhibitors with a low rate of transplacental passage should be used. Glucocorticoids may be considered at the lowest effective dose throughout pregnancy. Non-selective COX-inhibitors can be continued until gestational week 32. Together, a tailored treatment throughout pregnancy is possible with reasonable safety. Controlling disease activity during pregnancy is important for both, maternal and fetal health.Keywords
This publication has 65 references indexed in Scilit:
- Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceAnnals Of The Rheumatic Diseases, 2015
- Fertility in women with rheumatoid arthritis: influence of disease activity and medicationAnnals Of The Rheumatic Diseases, 2014
- The Epidemiology of Rheumatoid Arthritis in Ontario, CanadaArthritis & Rheumatology, 2013
- Interaction of pregnancy and autoimmune rheumatic diseaseAutoimmunity Reviews, 2012
- Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in SwedenAnnals Of The Rheumatic Diseases, 2010
- Disease activity of rheumatoid arthritis during pregnancy: Results from a nationwide prospective studyArthritis Care & Research, 2008
- Does rheumatoid arthritis remit during pregnancy and relapse postpartum?: Results from a nationwide study in the United Kingdom performed prospectively from late pregnancyArthritis & Rheumatism, 1999
- Maternal-Fetal Disparity in HLA Class II Alloantigens and the Pregnancy-Induced Amelioration of Rheumatoid ArthritisThe New England Journal of Medicine, 1993
- A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitisArthritis & Rheumatism, 1983
- Potential Reversibility of Rheumatoid ArthritisAnnals Of The Rheumatic Diseases, 1949